Model of Kennedy's disease requires the presence of the androgen receptor ligand dihydrotestosterone and is ameliorated by melatonin.
A significant reduction of locomotion is observed in the presence of dihydrotestosterone (DHT) in larvae expressing Hsap\ARS424A.S514A.Scer\UAS under the control of Scer\GAL4VGlut-OK371.
Larvae expressing Hsap\ARS424A.S514A.Scer\UAS under the control of Scer\GAL4VGlut-OK371 show neuromuscular junction abnormalities in the presence of DHT characterised by the noticeably reduced branching of the axons.
Expression of Hsap\ARS424A.S514A.Scer\UAS in the presence of dihydrotestosterone (DHT) under the control of Scer\GAL4GMR.PU results in the disruption of eye morphology.
Animals expressing Hsap\ARS424A.S514A.Scer\UAS under the control of Scer\GAL4elav.PLu demonstrate a marked decrease in survival at both the pupal and adult stages in the presence of DHT.
Larvae expressing Hsap\ARS424A.S514A.Scer\UAS under the control of Scer\GAL4elav.PLu display a significant reduction in locomotor speed and impaired directional movement upon DHT hormone treatment compared with controls. Melatonin, but not sodium butyrate, can significantly increase the speed of DHT-treated Hsap\ARS424A.S514A.Scer\UAS-expressing larvae. The opposite scenario is seen for the directional movement of the larvae measured by angular velocity. Treatment with sodium butyrate, but not melatonin, results in improved directional movement of DHT-treated Hsap\ARS424A.S514A.Scer\UAS-expressing larvae.